Inhibin assays of ovarian cyst liquid obtained by needle aspiration may allow differential diagnosis between functional and organic cysts

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 73, Issue 2, 1997, Pages 161-165

  Binelli, Christophe ^a   Chretien, Marie Françoise ^b   Yves, Gallois ^c   Kanaya, Malkani ^d   Alain, Denis ^a  

^a Serv de Gynecol Obstet   (France)

^b Lab d'Histol Embryologie Cytologie   (France)

^c Laboratoire de Biochimie B   (France)

^d Universite d'Angers   (France)

Author keywords

Functional cyst; Inhibin assay; Organic cyst; Ovarian cyst

Indexed keywords

INHIBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HORMONE DETERMINATION; HUMAN; NEEDLE BIOPSY; OVARY CYST; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030876560     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)02739-5     Document Type: Article

References (31)

1. Mage G, Canis H, Manhes H, Pouly JL, Bruhat MA. Kystes ovariens et coelioscopie. A propos de 266 observations. J Gynecol Obstet Biol Reprod 1987; 16: 1053-1061.
2. Forest AM, Bremond A, Leveque J, Viallet A. Places respectives de l'examen clinique, de l'échographie, des marqueurs biologiques et de la cytologie. J Gynecol Obstet Biol Reprod 1990; 19: 829-836.
3. Dargent D, Lasne JY, Akiki S. Diagnostic de la nature des kystes de l'ovaire par le dosage dans le fluide kystique et dans le sang des stéroides et des 'marqueurs tumoraux'; déductions pratiques. Contracept Fertil Sex 1990; 18(11): 1011-1016.
4. Audra P, Dargent D, Akiki S, Lasne JY, Malvoti B, Rebaud A. Ponction échoguidée des kystes de l'ovaire: possibilités et limites. Rev Fr Gynecol Obstet 1991; 11: 672-675.
5. De Meeus JB, Magnin G, Bounaud MP, Babin M. Place de la ponction échoguidée dans l'évaluation des tumeurs fluidiennes de l'ovaire. Rev Fr Gynecol Obstet 1993; 88(3): 142-145.
6. Mintz M, De Brux J. La ponction percoelioscopique et la cytologie de 347 kystes intrapelviens. Etude critique de ses indications diagnostiques et thérapeutiques. Gynécologie 1974; 25: 63-75.
7. McLachlan RI, Robertson DM, Healy DL, Burger HG, De Kretser DM. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 1987; 65(5): 954-961.
8. Franchimont P. L'inhibine. Ann Endocrinol Paris 1987; 48: 441-451.
9. Ying S. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle stimulating hormone. Endocrine Rev 1988; 9: 267-293.
10. Tsonis CG, Messinis IE, Templeton AA, Mc Neilly AS, Baird DT. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J Clin Endocrinol Metab 1988; 66: 915-921.
11. Channing CP, Gagliano P, Tanabe K, Fortuny A, Cortes Prieto J. Demonstration of a gradient in inhibin activity, estrogen progesterone and δ4 androstenedione in follicular fluid, ovarian vein blood and peripheral blood of normal women. Fertil Steril 1985; 43: 142-145.
12. Tanabe K, Gagliano P, Channing CP, Nakamura Y, Yoshimura Y, Ilzuka R, Fortuny A, Sulewski J, Rezai N. Level of inhibin-F activity and steroids in human follicular fluid from normal women with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 24-31.
13. Buckler HM, Mc Lachlan RI, Healy DL, Burger HG. Serum inhibin levels in polycystic ovary syndrome; basal levels and response to luteinizing hormone releasing hormone agonist and exogenous gonadotropin administration. J Clin Endocrinol Metab 1988; 66(4): 798-803.
14. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Rome R, Campbel J. Elevated serum inhibin concentration in postmenopausal women with ovarian tumors. N Engl J Med 1993; 329(21): 1539-1541.
15. Franchimont P, Hazee-Hagelstein MT, Charlet-Renard C, Jaspar JM, Hazout A, Salat-Baroux J, Shatz B, Demerle F. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer: Inhibin and aromatase inhibitor activity. J Clin Endocrinol Metab 1990; 71(3): 748-753.
16. Thirion B. Le CA125, nouveau marqueur tumoral. Bull Cancer (Paris) 1986; 73(3): 332-341.
17. Baird DT. Oestrogens in clinical practice. In: Loraine JA, Trevor Belle E, eds. Hormone assays and their clinical application. Edinburgh: Churchill Livingstone 1976; 408.
18. Poncelet E, Eliard P. Construction of a sensitive two-site immunoenzymatic assay for human inhibin in serum and other biological fluids. Abstracts of the 2nd joint ESCO-SHERE meeting, Milan 1990; 110-111.
19. Binelli C, Denis A, Chrétien MF, Wartanian R, Rosenau L, Grosieux P. Valeur des critères diagnostiques, cliniques, échographiques et biologiques dans la prise en charge des kystes de l'ovaire: à propos de 109 observations. Rev Fr Gynécol Obstet (in press).
20. Sassone M, Timor-Trish IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease; evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78(1): 70-76.
21. Jacobs P, Oram D, Fairbanks J, Tuner J, Frost C, Gruzinskias JG. A risk of malignancy index incorporating CA125 ultrasound in preoperative diagnosis of ovarian cancer. Br J Obstet Gynecol 1990; 97: 922-931.
22. Neunfeutel W, Breitenecker G. Tissue expression of CA125 in begnin and malignant lesions of the ovary and the fallopian tube: a comparison with CA199 and CEA. Gynecol Oncol 1989; 32(3): 297-302.
23. Ling N, Ying SY, Ueno N, Denoroy L, Guillemein R. Isolation and partial characterization of a Mr 32. 000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci 1985; 82: 7217-7221.
24. Miyamoto K, Hasegawa Y, Fukuda M. Isolation of porcine follicular fluid inhibin of 32 kDa. Biochem Biophys Res Commun 1985; 129: 396-403.
25. Rivier J, Spiess J, Mc Clintock R, Vaughan J, Vale W. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun 1985; 133: 120-127.
26. Vale W, Rivier J, Vaughan J, Mc Clintock R, Coorigan A, Woo W, Karr D, Spiess J. Purification and characterization of a FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776-779.
27. Biscak TA, Cajender SB, Vale W, Hseuh AJW. Inhibin: Studies of stored and secreted forms by biosynthetic labelling and immunodetection in cultured rat granulosa cells. Endocrinology 1988; 122: 741-748.
28. Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, De Bruijn H. Inhibin as a marker for granulosa cell tumors. N Engl J Med 1989; 321: 790-793.
29. Burger HG. Clinical review 46: Clinical utility of inhibin measurements. J Clin Endocrinol Metab 1993; 76(6): 1391-1396.
30. Healy DL, Mamers P, Bangah M, Burger HG. Clinical and physiopathological aspects of inhibin. Human Reprod 1993; 8: 138-140.
31. Halila H, Stenman UH, Seppala M. Ovarian cancer: Ag CA125 levels in pelvic inflammatory disease and pregnancy. Cancer 1986; 57: 1327-1329.